Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00996008

CT 327 in the Treatment of Atopic Dermatitis

Mild to Moderate Atopic Dermatitis Clinical Trial

Official title:
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study of the Safety and Efficacy of CT 327, Pegylated K-252, Formulated as a Cream, When Administered Twice Daily for 14 Days to Subjects With Mild-to-Moderate Atopic Dermatitis

Clinical Trial Summary

This study will look at how safe and effective, a novel agent, CT 327 cream is in treating patients with mild to moderate atopic dermatitis (AD). Patients will be treated twice daily for 14 days on specific lesions of AD and safety and symptoms of AD will be assessed throughout the treatment period.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00996008
Study type Interventional
Source Creabilis SA
Contact
Status Terminated
Phase Phase 2
Start date November 2009
Completion date October 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT05057351 - A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis N/A
Active, not recruiting NCT03250663 - Eucrisa for Atopic Dermatitis Phase 1
Not yet recruiting NCT06052995 - Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.
Completed NCT01568489 - Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis Phase 2
Completed NCT01079897 - Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis N/A
Completed NCT02079688 - Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema Phase 2
Not yet recruiting NCT05729074 - A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients Phase 1
Completed NCT00568412 - A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis Phase 4